Title : Physiologically Relevant Concentrations of Dolutegravir, Emtricitabine, and Efavirenz Induce Distinct Metabolic Alterations in HeLa Epithelial and BV2 Microglial Cells.

Pub. Date : 2021

PMID : 34093527






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dolutegravir (DTG) and emtricitabine (FTC) combination, together with tenofovir (TAF or TDF), is one of the recommended first line treatments for HIV. Tenofovir TATA-box binding protein associated factor 8 Homo sapiens